QCG
ETON icon

Quadrant Capital Group’s Eton Pharmaceutcials ETON Stock Holding History

Quadrant Capital Group’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-52
Closed – – 2447
2021
Q1 		$0 Hold
52
– – ﹤0.01% 2401
2020
Q4 		$0 Buy
+52
New +$401 ﹤0.01% 2319

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Quadrant Capital Group's ETON Position: Q2 2021 in Review

Quadrant Capital Group sold out of Eton Pharmaceutcials (ETON) in Q2 2021, closing a stake of 52 shares.

Quadrant Capital Group first reported a position in ETON in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 46 funds tracked by Wall St. Rank hold ETON as of Q2 2021.

  • Quadrant Capital Group reported no remaining Eton Pharmaceutcials position as of Q2 2021 after selling out during the quarter.
  • Quadrant Capital Group sold 52 Eton Pharmaceutcials shares in Q2 2021.
  • Quadrant Capital Group first reported a position in Eton Pharmaceutcials in Q4 2020 and held it in 2 quarters.
  • Quadrant Capital Group's Eton Pharmaceutcials position peaked at $0 in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2021.

Based on Quadrant Capital Group's 13F filing for Q2 2021, filed 9 Aug 2021.